{"id":"NCT03280537","sponsor":"Hoffmann-La Roche","briefTitle":"A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitus With Nasal Polyps","officialTitle":"A Phase III, Randomized, Multicenter, Double-blind, Placebo-controlled Clinical Trial of Omalizumab in Patients With Chronic Rhinosinusitis With Nasal Polyps","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-11-21","primaryCompletion":"2019-03-07","completion":"2019-03-07","firstPosted":"2017-09-12","resultsPosted":"2020-03-23","lastUpdate":"2020-03-23"},"enrollment":127,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Nasal Polyps","Chronic Rhinosinusitis"],"interventions":[{"type":"DRUG","name":"Omalizumab","otherNames":["Xolair","IGE025","RO5489789"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Omalizumab","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine the efficacy and safety of omalizumab compared with placebo in adult patients with chronic rhinosinusitis with nasal polyps (CRSwNP) who have had an inadequate response to standard-of-care treatments.\n\nStudy GA39688 (POLYP 1; NCT03280550) was another Phase III study by the Sponsor with identical objectives and design and was run in parallel with this study.","primaryOutcome":{"measure":"Change From Baseline in Nasal Polyp Score (NPS) at Week 24","timeFrame":"Baseline, Week 24","effectByArm":[{"arm":"Placebo","deltaMin":-0.31,"sd":null},{"arm":"Omalizumab","deltaMin":-0.9,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0140"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":12,"exclusionCount":24},"locations":{"siteCount":45,"countries":["United States","Belgium","Finland","France","Hungary","Mexico","Poland","Russia","Spain","Ukraine"]},"refs":{"pmids":["37951571","37214171","34382434","33710614","33548517"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":64},"commonTop":["Nasopharyngitis","Headache","Injection site reaction","Asthma","Epistaxis"]}}